Neil Martin

Neurosurgery UCLA Medical School, Los Angeles, CA, United States 
"Neil Martin"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hosking L, Yeo A, Hoffman J, et al. (2021) Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation. Respiratory Medicine. 187: 106573
Pavord ID, Bel EH, Bourdin A, et al. (2021) From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil driven diseases. Allergy
Bafadhel M, Barnes N, Bourke SC, et al. (2021) A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial. The European Respiratory Journal
Mallari RJ, Avery MB, Corlin A, et al. (2021) Streamlining brain tumor surgery care during the COVID-19 pandemic: A case-control study. Plos One. 16: e0254958
Harris TC, Seco J, Ferguson D, et al. (2021) Improvements in beam's eye view fiducial tracking using a novel multilayer imager. Physics in Medicine and Biology
Moore WC, Kornmann O, Humbert M, et al. (2021) Stopping continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study). The European Respiratory Journal
Dee EC, Muralidhar V, King MT, et al. (2021) Second malignancy probabilities in prostate cancer patients treated with SBRT and other contemporary radiation techniques. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 161: 241-250
Halpin DMG, Worsley S, Ismaila AS, et al. (2021) INTREPID: single- multiple-inhaler triple therapy for COPD in usual clinical practice. Erj Open Research. 7
Bansal S, Anderson M, Anzueto A, et al. (2021) Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD. Npj Primary Care Respiratory Medicine. 31: 29
Singh D, Criner GJ, Dransfield MT, et al. (2021) InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations. Respiratory Research. 22: 130
See more...